Infliximab: a novel treatment for sight-threatening thyroid associated ophthalmopathy

Orbit. 2005 Jun;24(2):117-9. doi: 10.1080/01676830590912562.

Abstract

We describe a patient with sight threatening thyroid associated ophthalmopathy (TAO) who was successfully treated with infliximab, an anti-tumour necrosis factor (TNF)-a antibody.

Publication types

  • Case Reports

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Eye Diseases / drug therapy*
  • Eye Diseases / etiology
  • Female
  • Graves Disease / complications*
  • Humans
  • Infliximab
  • Middle Aged
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors*

Substances

  • Antibodies, Monoclonal
  • Tumor Necrosis Factor-alpha
  • Infliximab